1. Activated AMP-protein kinase (pAMPK) is overexpressed in human somatotroph pituitary adenomas.
- Author
-
Bizzi MF, Drummond JB, Pinheiro SVB, Paulino E, Araújo SA, Soares BS, Giannetti AV, Schweizer JROL, Barry S, Korbonits M, and Ribeiro-Oliveira A
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Acromegaly genetics, Acromegaly pathology, Acromegaly metabolism, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Aged, Pituitary Neoplasms genetics, Pituitary Neoplasms pathology, Pituitary Neoplasms metabolism, Pituitary Neoplasms enzymology, Phosphorylation, Pituitary Gland metabolism, Pituitary Gland pathology, Gene Expression Regulation, Neoplastic, AMP-Activated Protein Kinases metabolism, AMP-Activated Protein Kinases genetics, Growth Hormone-Secreting Pituitary Adenoma genetics, Growth Hormone-Secreting Pituitary Adenoma metabolism, Growth Hormone-Secreting Pituitary Adenoma pathology, Adenoma genetics, Adenoma pathology, Adenoma metabolism, Adenoma enzymology
- Abstract
Introduction: AMPK (AMP-activated protein kinase) is an enzyme that acts as a metabolic sensor and regulates multiple pathways via phosphorylating proteins in metabolic and proliferative pathways. The aim of this work was to study the activated cellular AMPK (phosphorylated-AMPK at Thr172, pAMPK) levels in pituitary tumor samples from patients with sporadic and familial acromegaly, as well as in samples from normal human pituitary gland., Methods: We studied pituitary adenoma tissue from patients with sporadic somatotroph adenomas, familial acromegaly with heterozygote germline variants in the aryl hydrocarbon receptor interacting protein (AIP) gene (p.Q164*, p.R304* and p.F269_H275dup) and autopsy from normal pituitary glands without structural alterations., Results: Cellular levels of pAMPK were significantly higher in patients with sporadic acromegaly compared to normal pituitary glands (p < 0.0001). Tissues samples from patients with germline AIP mutations also showed higher cellular levels of pAMPK compared to normal pituitary glands. We did not observe a significant difference in cellular levels of pAMPK according to the cytokeratin (CAM5.2) pattern (sparsely or densely granulated) for tumor samples of sporadic acromegaly., Conclusion: Our data show, for the first time in human cells, an increase of cellular levels of pAMPK in sporadic somatotropinomas, regardless of cytokeratin pattern, as well as in GH-secreting adenomas from patients with germline AIP mutations., Competing Interests: Declaration of competing Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. MFB and AROJr are current full-time employees at Ipsen in Brazil and USA, respectively. AROJr has stock shares from Ipsen., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF